Real-World Evidence and Treatment Patterns: Head and Neck Cancer

Bristol-Myers Squibb (BMS)

Status: Completed

Conditions: Head & Neck Cancer

Treatments: Other: Non-Interventional

Study type: Observational

Funder types: Industry

Identifiers

NCT03157674

CA209-868

Details and patient eligibility

About

This study will be focused on HNC patients who have been diagnosed with HNC between 01-Jan-2013 and 30-Sep-2016.

Enrollment: 43,994 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• HNC or undefined histology (not otherwise specified [NOS]) HNC diagnosis from 01-Jan-2013 to 30-Sep-2016 using Japanese disease code
• Age 18 years or older at initial diagnosis of HNC regardless of staging

Exclusion criteria

• Diagnosis of another malignancy on or before the initial diagnosis of HNC with the exception of non-melanoma skin cancer and metastatic cancer
• Diagnosis of HNC before 01-Jan 2013 or after 30-Sep-2016

Trial design

43,994 participants in 1 patient group

HNC patients

Description:

HNC patients who have been diagnosed with HNC between 01-Jan-2013 and 30-Sep-2016.

Treatment:

Other: Non-Interventional